5-[18F]Fluoroalkyl pyrimidine nucleosides: probes for positron emission tomography imaging of herpes simplex virus type 1 thymidine kinase gene expression☆
Abstract
Introduction
The preliminary in vivo evaluation of novel 5-[18F]fluoroalkyl-2′-deoxyuridines ([18F]FPrDU, [18F]FBuDU, [18F]FPeDU; [18F]1a−c, respectively) and 2′-fluoro-2′-deoxy-5-[18F]fluoroalkyl-1-β-d-arabinofuranosyl uracils ([18F]FFPrAU, [18F]FFBuAU, [18F]FFPeAU; [18F]1d−f, respectively) as probes for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene expression is described.
Methods
[18F]1a−f were successfully synthesized by a rapid and efficient two-step one-pot nucleophilic fluorination reaction using 5-O-mesylate precursors and [18F]F−. For in vivo studies, tumor xenografts were grown in nude mice by implanting RG2 cells stably expressing HSV1-tk (RG2TK+) and wild-type cells (RG2).
Results
Biodistribution studies at 2 h pi revealed that the uptake of [18F]1a−b and [18F]1d−e in RG2TK+ tumors was not significantly different from control tumors. However, [18F]1c and [18F]1f had an average 1.6- and 1.7-fold higher uptake in RG2TK+ tumors than control RG2 tumors. Blood activity curves for [18F]1c and [18F]1f highlight rapid clearance of radioactivity in the blood. Dynamic small animal PET (A-PET) imaging studies of tumor-bearing mice with [18F]1c and [18F]1f showed higher initial uptake (3.5- and 1.4-fold, respectively) in RG2TK+ tumors than in control tumors, with continued washout of activity from both tumors over time.
Conclusions
Biological evaluations suggest that [18F]1c and [18F]1f may have limited potential for imaging HSV1-tk gene expression due to fast washout of activity from the blood, thus significantly decreasing sensitivity and specificity of tracer accumulation in HSV1-tk-expressing tumors.
Keywords: 5-[18F]Fluoroalkyl pyrimidine nucleosides, HSV1-tk, PET, Reporter gene imaging
To access this article, please choose from the options below
☆ This work was supported by a grant awarded from the National Institutes of Health (R21-EB-005242) to H.F.K. A travel award to A.-M.C. from the Educational Research Fund of the Society of Nuclear Medicine (SNM) supported the presentation of the preliminary results at the 2008 SNM Annual Meeting in New Orleans, LA.
PII: S0969-8051(08)00204-7
doi:10.1016/j.nucmedbio.2008.10.009
© 2009 Elsevier Inc. All rights reserved.
